Peakdale Extends its Range of Medicinal Chemistry Services
Peakdale Molecular Ltd announced the extension of its medicinal chemistry Services to further support its customers' drug discovery programmes. The services enable the Company to provide compounds with a superior starting point for hit discovery, resulting in significant savings for subsequent optimisation.
Peakdale's Medicinal Chemistry Services are designed to complement its customers' drug discovery initiatives through hit-to-lead and lead optimisation projects, patent protection projects, back-up chemotypes and fast follower candidate programmes. They also include the synthesis of chemogenetic arrays on an exclusive basis utilising Peakdale's unique, privileged scaffolds. The services are underpinned by Peakdale's strength in CADD, used to simulate drug-receptor interactions.
Other news from the department research and development
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.